China
Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform
Porton Advanced CDMO offers end-to-end gene and cell therapy services covering plasmids, cell therapy, gene therapy, oncolytic virus, mRNA therapy, and bac...
February 27, 2023 | News
Medtec China 2023 will be held on June 1-3, 2023, in Suzhou China
Meanwhile, the most recent COVID-19 prevention and control optimization policies have made it easier for overseas enterprises to participate in trade fairs...
February 27, 2023 | News
Keymed and Lepu Biopharma gain global exclusive license for CMG901 from AstraZeneca.
CMG901 is currently in a Phase I clinical trial for the treatment of Claudin 18.2-positive solid tumors. Preliminary results from the Phase 1 trial indicat...
February 24, 2023 | News
Zhongchao Inc. Renews Partnership with Johnson & Johnson (China)
The renewed partnership is expected to further strengthen two parities' cooperation in the global advanced field of innovative medical and health. As the ...
February 24, 2023 | News
Fapon Biopharma's Anti-CD47 Antibody FP002 Earns IND Approval from FDA
FP002 is a humanized anti-CD47 IgG4 monoclonal antibody, developed and patented by Fapon Biopharma. It binds strongly to the CD47 protein on the surface of...
February 23, 2023 | News
AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study
To date, the study has enrolled over 18,000 individuals from a general population of 230,000 persons located in China. The test subjects were tested ...
February 23, 2023 | News
Neurophth completes Phase III trial enrollment for LHON gene therapy
Neurophth Therapeutics, Inc. ("Neurophth") announced today that the last patient has been enrolled in the Phase III clinical trial for the treatment o...
February 22, 2023 | News
Duoning Enters Partnership with BioAces to Expand Cell Analysis Portfolio
Duoning obtained exclusive license from BioAces for its cell analysis portfolio Through the partnership, the two companies will advance the development ...
February 21, 2023 | News
Clover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China
-- Clover to leverage its established and growing commercial infrastructure to exclusively distribute Adimmune’s AdimFlu-S (QIS), the only imported q...
February 20, 2023 | News
Boan Biotech's Investigational Long-acting Anti-IL-4Rα Antibody BA2101 Administered for First Patient in Phase I Clinical Trial
BA2101 is the first long-acting anti-IL-4Rα monoclonal antibody that enters the clinical trial stage in the country. It is intended to be used for tr...
February 16, 2023 | News
BioDuro-Sundia Expands Drug Discovery Capacity and Capability
Dr. Xiang Li, President of BioDuro-Sundia Drug Discovery, explains: “At BioDuro-Sundia, we are fully invested in our clientele and pro-actively plann...
February 15, 2023 | News
AnPac Bio-Medical Science Expand Scope of Business in the U.S.
AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations in the United States and China announced ...
February 14, 2023 | News
Boan Biotech's Investigational Anti-CD25 Antibody BA1106 Administered for First Patient in Phase I Clinical Trial
BA1106 is the first investigational anti-CD25 antibody to start clinical trials in China for treating solid tumors. Focusing on key therapeutic a...
February 13, 2023 | News
Everest Medicines Announces South Korea Grants Fast Track Review Designation to Nefecon for the Treatment of Primary IgA Nephropathy
This demonstrates the urgent unmet medical needs for Nefecon, as Everest also received Priority Review status for the New Drug Application (NDA) of Nefecon...
February 10, 2023 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
